心血管疾病中的乳化:表观遗传机制和治疗潜力
Meican Ma1, Chong Xu2, Hong Zhou3
1Department of Rheumatology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi 214023, China.
Journal of cardiovascular pharmacology
|August 15, 2025
概括
乳糖化是一种乳酸的表观遗传修饰,在心血管疾病 (CVD) 中起着关键作用. 针对这种可逆的过程,为心脏病提供了新的治疗策略.
科学领域:
- 生物化学 生物化学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 心血管医学 心血管医学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 改变的代谢平衡是心血管疾病发病的一个关键因素.
- 乳酸盐是糖溶解的副产物,现在通过乳糖化被认为是一种信号分子.
研究的目的:
- 审查心血管疾病中乳糖化机制的洞察力.
- 突出乳化在心肌缺血,动脉样硬化和心力衰竭中的作用.
- 探索新陈代谢-表观遗传疗法的可用药物标.
主要方法:
- 关于心血管疾病中乳化机制的综合文献综述.
- 对乳化对转录调节,代谢适应和细胞分化影响的分析.
- 评估酶调节的可逆性和可药物治疗的乳糖化标.
主要成果:
- 乳显著促进心肌缺血,动脉样硬化和心力衰竭的发病.
- 乳化调节关键的细胞过程,包括基因表达和分化.
- 乳化的可逆性为治疗干预提供了机会.
结论:
- 乳化是心血管疾病中关键的表观遗传调节剂.
- 向乳化为心血管疾病提供了一个新的治疗途径.
- 结合新陈代谢和表观遗传疗法对治疗心血管疾病充满希望.
更多相关视频
相关概念视频
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Epigenetic Regulation
31.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Regulation of the Cardiovascular System
1.8K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.8K
Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.1K


